Reporting owner · CIK 0002048500

Mensinger Mike

Visual SEC Form 4 history across 1 companies, 16 transactions and 6 filings.

CPOChief Product OfficerBeta Bionics, Inc.
Open-market mix
Latest filingSep 03, 2026, 10:15 PM
Filings6Form 4 records
Buying$567K1 purchases
Selling$381K5 sales
Net value$185.9KBuys minus sells
Companies14 securities
Most recentSep 02, 2026sale

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for some of their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-511Jan 25Feb 253Jan 261Sep 26

Net value flow

Buys minus sells

Jan 25
$566.7K
Feb 25
$0
Jan 26
−$297.2K
Sep 26
−$83.6K

Transaction texture

Ownership and ticket size

Average P/S size$158K
Median P/S size$74.9K
Direct16
Indirect0
Sep 02, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Cluster Buypattern1Cluster Sellingpattern1Derivative Transactionfiling-context7Direct Ownershipfiling-context15Large Holdings Increaseholdings9Large Salesize1Repeat Sellerpattern210b5-1 Detectedfiling-context3

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Beta Bionics, Inc. on Sep 02, 2026 valued at $83,620.

Review SEC filing
Latest sale

sale at Beta Bionics, Inc. on Sep 02, 2026 valued at $83,620.

Review SEC filing

Associated companies

Visual map of known reporting history

BBNXBeta Bionics, Inc.16 transactions · latest Sep 03, 2026, 10:15 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
BBNXMensinger Mike
CPO
sale4.37k-$8.36MS
Cluster Selling Direct Ownership
0.0%09/0309/02
BBNXMensinger Mike
CPO
sale10b5-12.20k-$6.62MS
Cluster Selling Direct Ownership Large Sale+2
—01/0701/06
BBNXMensinger Mike
CPO
sale10b5-1600-$1.81MS
Direct Ownership Repeat Seller 10b5-1 Detected
−65.8%01/0501/02
BBNXMensinger Mike
CPO
sale10b5-17.20k-$21.2MS
Direct Ownership 10b5-1 Detected
−65.8%01/0501/02
BBNXMensinger Mike
CPO
grant52.0k$0A
Derivative Transaction Direct Ownership Large Holdings Increase
—03/03/202502/27/2025
BBNXMensinger Mike
CPO
grant35.0k$0A
Direct Ownership Large Holdings Increase
—03/03/202502/27/2025
BBNXMensinger Mike
CPO
grant110k$0A
Derivative Transaction Direct Ownership Large Holdings Increase
—02/04/202501/31/2025
BBNXMensinger Mike
CPO
grant236k$0A
Derivative Transaction Direct Ownership Large Holdings Increase
—02/04/202501/31/2025
BBNXMensinger Mike
CPO
exercise10.5k$0X
Derivative Transaction Direct Ownership
—02/04/202501/31/2025
BBNXMensinger Mike
CPO
C10.5k$0C
Derivative Transaction Direct Ownership Large Holdings Increase
—02/04/202501/31/2025

Mensinger Mike Insider Activity FAQ

SEC Form 4 context

Who is Mensinger Mike?

Mensinger Mike is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002048500.

Which companies has Mensinger Mike reported transactions for?

Beta Bionics, Inc.

When was Mensinger Mike's latest insider buy?

buy at Beta Bionics, Inc. on Jan 31, 2025 valued at $566,950.

When was Mensinger Mike's latest insider sale?

sale at Beta Bionics, Inc. on Sep 02, 2026 valued at $83,620.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.